trial · primary record
DNL126
Mucopolysaccharidosis Type IIIA
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2032-07 |
| Primary endpoint | Part 1: Change from baseline in the natural logarithm of cerebrospinal fluid (CSF) heparan sulfate (HS) concentration |
| Registry ID | NCT06181136 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:43.800Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06181136
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.